Join American Red Cross Cell and Gene Therapy Solutions on June 29-30, 2022, in Boston, MA at the ONCO Cell Therapy Summit, where on Wednesday, June 29 at 5 PM ET, Melissa Sebok, Executive Director of Product, Client & Business Development will be presenting, Partnering with Key Raw Material Providers to Ensure Timely Scale-Up in Support of Clinical Trials and Commercial Launch.
During this session on Wednesday, June 29 at 5 PM ET, Melissa will share how Red Cross Cell and Gene Therapy Solutions has supported the development and commercial launch of cellular therapies and discuss the benefit of close collaboration to ensure timelines and expectations are met.
The manufacture of cell and gene therapies relies on critical raw material sourcing from specialized vendors. Laying out a timeline for the progression of development between clinical trial phases and eventual commercial launch is crucial but challenging.
This presentation will cover how working closely with key raw material providers to plan for supporting progression through clinical trial phases and eventual commercial launch can help ensure that supply of such materials does not limit the development and commercial success of the therapy.
Executive Director, Product, Client & Business Development
Direct Patient Care & Emerging Offerings
American Red Cross
Melissa Sebok is responsible for product and business development for Direct Patient Care & Emerging Offerings at the American Red Cross. Her product portfolio includes Cell & Gene Therapy Solutions, which encompasses services provided to biotechnology and pharmaceutical companies in support of their development and commercialization of cellular therapies.
Melissa has been involved in the Red Cross’s provision of leukapheresis services since 2010 and has worked with multiple clients across varying stages of development and commercialization. Melissa has a BS in Finance from the Pennsylvania State University and an MBA from Carnegie Mellon University.
You can request a quote for products and services by completing our contact form